[Clinical use of thrombolytic agents].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D004359:Drug Therapy, Combination; D005340:Fibrinogen / Q000032:analysis; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006487:Hemostasis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D013300:Streptokinase / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D005340:Fibrinogen; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Utilisation clinique des thrombolytiques.